MARKERS OF INCREASED RISK OF SUDDEN CARDIAC DEATH IN PATIENTS WITH STABLE ANGINA AND ARTERIAL HYPERTENSION: ASSOCIATION WITH THE PROGRESSION OF LEFT VENTRICULAR HYPERTROPHY

Aim. To analyse the markers of sudden cardiac death (SCD) in patients with stable angina and arterial hypertension (AH), in regard to the progression of left ventricular hypertrophy (LVH). Material and methods. In total, 90 patients with Functional Class II–III stable angina, AH, and LVH were examined. The following parameters were assessed: left ventricular myocardial mass index (LVMMI), left ventricular ejection fraction (LVEF), heart rate variability (HRV) parameters (SDNN, HRVi, CBBP); mean 24-hour HR levels, QT and QTc intervals, QT dispersion (QTds), ectopic ventricular activity; mean 24-hour blood pressure (BP) levels; levels of serum markers of myocardial collagenolysis and N-terminal pro-brain natriuretic peptide (NT-proBNP). Results. In all participants, LVEF was preserved, without significant difference between the tertiles. The increase in LVMMI was linked to a significant increase in the total number of ventricular extrasystoles (VE) over 24 hours (p<0,001) and the mean number of paired (p><0,008) and polytopic (p>< 0,011) VE per patient; reduced HRV, based on the SDNN dynamics (p=0,004); increased mean 24-hour pulse BP (p=0,003); elevated levels of tissue inhibitors of matrix metalloproteinase-1 (p=0,017) and NT-proBNP; and decreased levels of procollagen type I C-terminal telopeptide (p=0,011). Conclusion. In patients with stable angina, AH, and preserved LVEF, the LVH progression is associated with an increased number of SCD markers: increased ventricular ectopic activity, reduced HRV, increased mean 24-hour BP, and elevated levels of NT-proBNP and serum markers of myocardial fibrosis, which confirms the increase in the risk of SCD in parallel to the increase in the LVMMI.

1. Myerburg R.J., Junttila M.J. Sudden cardiac death caused by coronary heart disease. Circulation 2012; 125 (8):1043–52.

2. Erbel R., Budoff M. Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure. Eur Heart J 2012; 33 (10):1201–13.

3. Barison A., Vergaro G., Pastormerlo L.E. et al. Markers of arrhythmogenic risk in hypertensive subjects. Curr Pharm Des 2011; 17 (28):3062–73.

4. Paoletti E., Specchia C., Di Maio G. et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004; 19 (7):1829–34.

5. Lahtinen A.M., Noseworthy P.A., Havulinna A.S. et al. Common Genetic Variants Associated with Sudden Cardiac Death: The FinSCDgen Study. PLoS One 2012; 7 (7): e41675.

6. Marchesi C., Dentali F., Nicolini E. et al. Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis. J Hypertens 2012; 30 (1):3–16.

7. Reinier K., Dervan C., Singh T. et al. Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. Heart Rhythm 2011; 8 (8):1177–82.

8. Stecker E.C., Vickers C., Waltz J. et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 2006; 47 (6):1161–6. Литература

9. Kunisek J., Zaputović L., Mavrić Z. et al. Influence of the type and degree of left ventricular hypertrophy on the prevalence of ventricular arrhythmias in patients with hypertensive heart disease. Med Klin (Munich) 2008; 103 (10):705–11.

10. Wang H.B., Shi Q., Zhang C. Effects of heart rate variability and smoothness index on the reversal of hypertensive left ventricular hypertrophy. Zhonghua Yi Xue Za Zhi 2011; 91 (12):832–5.

11. Kurl S., Mäkikallio T. H., Rautaharju P. et al. Duration of QRS complex in resting electrocardiogram is a predictor of sudden cardiac death in men. Circulation 2012; 125 (21):2588–94.

12. Klimas J., Stankovicova T., Kyselovic J., Bacharova L. Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats. Clin Exp Hypertens 2008; 30 (7):475–85.

13. Laukkanen J. A., Jennings J.R., Kauhanen J. et al. Relation of systemic blood pressure to sudden cardiac death. Am J Cardiol 2012; 110 (3):378–82.

14. Franz M., Berndt A., Altendorf-Hofmann A. et al. Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy. Eur J Heart Fail 2009 Nov;11 (11):1057–62.

15. Roselló-Lletí E., Calabuig J. R,, Morillas P. et al. Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study. PLoS One 2012; 7 (2): e31189.